Erratum to clostridium butyricum alleviates dextran sulfate sodium-induced experimental colitis and promotes intestinal lymphatic vessel regeneration in mice
Erratum to: Ann Transl Med 2022;10:341
This article (1) titled “Clostridium butyricum alleviates dextran sulfate sodium-induced experimental colitis and promotes intestinal lymphatic vessel regeneration in mice” (doi: 10.21037/atm-22-1059), unfortunately contains an error in the funding information. The grant number of Shandong Provincial Key Research and Development Program (No. GG201809230187) should be corrected to Shandong Provincial Key Research and Development Program (No. 2019GSF108188). The corrected funding information is as follows.
Funding: This work was supported by the Major Science and Technology Innovation Project of Shandong Province (No. 2018CXGC1220); Shandong Provincial Key Research and Development Program (No. 2019GSF108188); National Natural Science Foundation of China (No. 81801983); Traditional Chinese Medicine Science and Technology Development Plan of Shandong Province (No. 2019-0377); Qianfoshan Grant (Nos. QYPY2020NSFC1015, QYPY2020NSFC0821).
The authors apologize for the oversight.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Chen X, Ma L, Liu X, et al. Clostridium butyricum alleviates dextran sulfate sodium-induced experimental colitis and promotes intestinal lymphatic vessel regeneration in mice. Ann Transl Med 2022;10:341. [Crossref] [PubMed]
